Continuous glucose monitor use in type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 80 years old
- You have type 2 diabetes and do not use insulin
- Your diabetes treatment (pills, GLP-1 injections, or lifestyle changes) has been stable for at least 3 months
- Your recent HbA1c blood test is between 7.5% and 10.0%
- You are willing to wear a CGM device and use its app on your smartphone with internet access
- You can read and write Korean
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether patient-guided lifestyle changes, supported by a continuous glucose monitor (a sensor), can improve blood sugar control in adults with type 2 diabetes. It may help you and your care team see how food, activity, and habits affect your readings.
This study uses a continuous glucose monitor to help people with prediabetes or type 2 diabetes better manage their blood sugar and weight, and will test how well it works in a real-world workplace setting.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
This study tests whether using a continuous glucose monitor (CGM) helps people who were just diagnosed with type 2 diabetes manage their blood sugar better. Participants wear a small sensor on their arm that checks sugar levels all the time.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This study tests whether using a continuous glucose monitor (FreeStyle Libre 2) along with smart insulin pens or caps helps people with type 1 diabetes better manage their blood sugar on their own. If you already use this device and take multiple daily insulin injections, you may be eligible.
Hear when a new Diabetes Mellitus, Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.